DiaSorin S.p.A.'s latest marketcap:
As of 07/05/2025, DiaSorin S.p.A.'s market capitalization has reached $5.73 B. According to our data, DiaSorin S.p.A. is the 3007th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.73 B |
| Revenue (ttm) | 1.42 B |
| Net Income (ttm) | 228.55 M |
| Shares Out | 53.89 M |
| EPS (ttm) | 4.24 |
| Forward PE | 20.58 |
| Ex-Dividend Date | 05/19/2025 |
| Earnings Date | 07/31/2025 |
DiaSorin S.p.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €5.73 B | -8.28% | 3007 |
| 12/30/2024 | €5.31 B | 6.83% | 2782 |
| 12/29/2023 | €4.97 B | -28.63% | 2671 |
| 12/30/2022 | €6.96 B | -24.02% | 1916 |
| 12/30/2021 | €9.16 B | -1.36% | 1740 |
| 12/30/2020 | €9.29 B | 47.09% | 1470 |
| 12/30/2019 | €6.31 B | 63.28% | 1802 |
| 12/28/2018 | €3.87 B | -4.56% | 2249 |
| 12/29/2017 | €4.05 B | 31.58% | 2388 |
| 12/30/2016 | €3.08 B | 16.79% | 2738 |
Company Profile
About DiaSorin S.p.A.
DiaSorin S.p.A. is a leading global company specializing in the development, manufacturing, and distribution of immunodiagnostic and molecular diagnostic testing kits. Operating across Europe, North America, and international markets, the company plays a pivotal role in advancing diagnostic solutions.
Key Products & Technologies
- LIAISON Chemiluminescence Analyzers: Including the LIAISON XL and LIAISON XS systems for high-performance immunodiagnostic testing.
- Simplexa Congenital CMV Direct Kit: A cutting-edge molecular diagnostic tool designed to detect cytomegalovirus (CMV) DNA in saliva swab and urine specimens.
Company Background
Founded in 1968, DiaSorin is headquartered in Saluggia, Italy. With decades of expertise, the company continues to innovate in the diagnostics industry, delivering reliable and efficient testing solutions worldwide.
Frequently Asked Questions
-
What is DiaSorin S.p.A.'s (BIT-DIA) current market cap?As of 07/05/2025, DiaSorin S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $5.73 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does DiaSorin S.p.A. (BIT-DIA) rank globally by market cap?DiaSorin S.p.A. global market capitalization ranking is approximately 3007 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.